This inventor holds 1 USPTO granted patent and 1 published patent application and 3 EPO patents. Top assignee: Vio Ag Pharmaceuticals S.a.. Active years: 2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021
Title: The Innovative Contributions of Theocharis V Koftis
Introduction
Theocharis V Koftis is a notable inventor based in Salonika, Greece. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative approaches to chemical processes. His work exemplifies the intersection of creativity and scientific rigor, leading to advancements in drug development.
Latest Patents
Theocharis holds a patent for a novel process titled "One-pot organo-pseudocatalytic C—H activation approach for the preparation of vortioxetine and vortioxetine intermediate." This invention relates to a unique method for synthesizing Vortioxetine and its key intermediate using a one-pot organo-pseudocatalytic C—H activation approach via hypervalent iodine chemistry. This innovative technique has the potential to streamline the production of important pharmaceutical compounds.
Career Highlights
Theocharis is currently associated with Vio Ag Pharmaceuticals S.A., where he continues to push the boundaries of pharmaceutical research and development. His expertise in chemical processes has been instrumental in advancing the company's objectives and enhancing its product offerings.
Collaborations
Throughout his career, Theocharis has collaborated with talented professionals, including Efstratios Neokosmidis and Thanos Andreou. These collaborations have fostered a dynamic environment for innovation and have contributed to the successful development of new pharmaceutical solutions.
Conclusion
Theocharis V Koftis stands out as a pioneering inventor in the pharmaceutical industry. His innovative patent and collaborative efforts highlight his commitment to advancing drug development through creative scientific approaches. His contributions are a testament to the impact of innovation in improving healthcare solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile